12 Health Care Stocks Moving In Friday's Pre-Market Session

Gainers

  • Adial Pharmaceuticals ADIL shares rose 76.0% to $3.59 during Friday's pre-market session. The company's market cap stands at $5.9 million.
  • BioVie BIVI shares moved upwards by 75.8% to $2.18. The company's market cap stands at $86.9 million.
  • Bone Biologics BBLG shares rose 28.97% to $3.16. The market value of their outstanding shares is at $1.6 million.
  • Y-mAbs Therapeutics YMAB stock moved upwards by 21.49% to $20.29. The company's market cap stands at $885.0 million. As per the news, the Q4 earnings report came out yesterday.
  • Cardiff Oncology CRDF shares increased by 18.41% to $2.09. The company's market cap stands at $93.3 million. The company's, Q4 earnings came out yesterday.
  • Biodesix BDSX stock rose 17.53% to $1.81. The market value of their outstanding shares is at $163.7 million. As per the news, the Q4 earnings report came out today.

Losers

  • Scilex Holding SCLX shares declined by 35.7% to $1.46 during Friday's pre-market session. The company's market cap stands at $230.5 million.
  • Humacyte HUMA shares declined by 25.52% to $3.24. The market value of their outstanding shares is at $335.5 million.
  • Gritstone Bio GRTS stock declined by 21.08% to $2.21. The company's market cap stands at $210.7 million.
  • Precision BioSciences DTIL shares fell 20.55% to $14.7. The company's market cap stands at $59.7 million.
  • Vivani Medical VANI shares decreased by 19.92% to $3.38. The company's market cap stands at $172.4 million.
  • DermTech DMTK stock fell 16.41% to $1.07. The market value of their outstanding shares is at $36.6 million. As per the press release, Q4 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!